Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older.
The Centers for Medicare and Medicaid Services has deferred coverage for CT colonography primarily citing a lack of data on the exam’s performance in Medicare-eligible recipients ages 65 and older.
“Our goal in carrying out this secondary analysis was to determine if the accuracy of CT colonography to detect polyps of clinical concern in patients 65 and older is comparable to the test’s accuracy for the 50 and over population studied in the 2008 ACRIN trial. We found no significant difference in the screening exam’s performance between the two age groups,” said C. Daniel Johnson, MD, of the Mayo Clinic in Scottsdale, AZ and principal investigator of the National CT Colonography Trial and the paper’s primary author.
“CT colonography is a perfectly viable colorectal cancer screening tool for the traditional Medicare age population. Wider availability made possible by Medicare coverage of CT colonography would attract more seniors to be screened for colorectal cancer – which is so successfully treated when detected early. Making CT colonography more available to seniors ultimately could save lives,” summarizes Johnson.
The National CT Colonography Trial recruited 2,600 study participants ages 50 and over from 15 US medical centers to compare the accuracy of state-of-the-art CT colonography to the gold standard of conventional colonoscopy. Ninety percent of the polyps 1 centimeter or larger – the polyps most likely to become cancerous – were detected by CT colonography. Polyps as small as one-half centimeter were also detected by CT colonography with a high degree of accuracy.
CT colonography employs virtual reality technology to produce a three-dimensional visualization that permits a thorough and minimally invasive evaluation of the entire colon and rectum. The ACRIN trial is the largest multi-center study to compare the accuracy of state-of-the-art CT colonography to the gold standard of conventional colonoscopy in patients 50 and older.
Colorectal cancer is the third most frequently diagnosed cancer and second leading cause of cancer death in men and women in the United States. Yet, despite the known benefits of screening, studies indicate that millions of Americans age 50 and older are not being screened for the disease.
Source: American College of Radiology, USA
- « Regorafenib improves survival of colorectal cancer patients
- Colorectal cancer
- Zaltrap for metastatic colorectal cancer approved by FDA »
Editor Health NewsCT colonography a front line colorectal cancer screening tool for seniors
by Editor Health News ( Author at Health Newstrack )
Posted on February 24th, 2012 at 7:49 am.
Track Health News on: Colorectal cancer